Rocket Lab Faces FCC Comment Deadline as Analysts Trim Targets but Keep the Faith

Rocket Lab's Iridium license comment window closes Oct 15 as TD Cowen cuts its target to $90 and Barclays starts at Overweight with an $85 target.

The commercial space race is entering a starker chapter, one in which balance-sheet heft may matter more than engineering pedigree. Rocket Lab finds itself at the center of that shift, with a regulatory clock ticking, a marquee launch on the calendar, and a share price that has surrendered a large chunk of its former altitude.

Thursday, October 15 marks the deadline for comments and petitions at the US Federal Communications Commission concerning the transfer of licenses tied to Rocket Lab's proposed acquisition of Iridium. That filing window is the next procedural gate in a deal meant to plant the company squarely in the satellite direct-to-device arena — the same segment where SpaceX recently agreed to pay $8 billion for a spectrum portfolio from Grain Management, a move that raises pointed questions about how crowded the competitive field will become.

Wall Street Trims, but Does Not Retreat

Analysts have been recalibrating rather than capitulating. TD Cowen's Gautam Khanna cut his price target to $90 from $120 last Friday as part of a third-quarter sector review, while leaving his Buy rating untouched. Barclays, meanwhile, initiated coverage on October 8 with an Overweight rating and an $85 target. Both houses still see upside; they have simply tightened the valuation reins in response to a changed industry backdrop, which TD Cowen characterized as disorderly.

The stock's recent path tells its own story. Rocket Lab closed Wednesday at €57.40, down 2.5% on the day, with no company-specific news or fresh sector data to explain the slide. That print sits roughly 57% below the 52-week high of €133.80, and about 19% under its 200-day moving average — a technically demanding stretch by any measure.

A Backlog Above 100 Launches

Operationally, the picture is steadier. A multi-year agreement signed with Synspective in late September for 20 Electron missions pushed the order book past the 100-launch mark, a deal the company described as its largest commercial contract ever for that rocket class. The next milestone is already in view: media accreditation for Rocket Lab's 100th launch closes today at 23:59 UTC, with the mission itself slated for November 2026, subject to change.

That the 100th-launch announcement landed roughly two weeks ago — and the shares have shed about 12.6% since — captures the current paradox. Genuinely positive operational news is being swallowed by broader market noise. When even a historic milestone fails to draw buyers, macroeconomic caution is clearly calling the tune, amplified by rising US Treasury yields and firmer oil prices that have stoked risk aversion across growth names.

Capital Power vs. Delivery Discipline

The wider maneuvering in the sector underscores the stakes. SpaceX has reportedly explored a debt package of as much as $40 billion for Nvidia computing infrastructure, a reminder that financial firepower on that scale can reshape competitive dynamics almost overnight.

For Rocket Lab, a well-stocked manifest is no longer enough on its own to steady the market. If deep-pocketed rivals set the pace on new satellite services, the company must show that reliable execution can hold its ground against sheer capital might. Sentiment has cooled noticeably, and pullbacks without fundamental triggers have become routine in this segment — yet the unchanged positive ratings from major research houses and the upcoming launch calendar suggest the longer-term case still outweighs the near-term chop.